Stockscreener 앱 받기
74.18
0.58%
-0.43
시간 외 거래:
74.18
전일 마감가:
$74.61
열려 있는:
$74.61
하루 거래량:
593.39K
Relative Volume:
0.99
시가총액:
$3.73B
수익:
$379.25M
순이익/손실:
$-77.34M
주가수익비율:
-46.01
EPS:
-1.6122
순현금흐름:
$-27.87M
1주 성능:
-1.79%
1개월 성능:
+42.00%
6개월 성능:
+64.04%
1년 성능:
+77.46%
1일 변동 폭
$73.26
$74.83
1주일 범위
$73.12
$76.02
52주 변동 폭
$36.86
$76.02
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
명칭
Mirum Pharmaceuticals Inc
전화
650-667-4085
주소
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
MIRM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
74.18 | 3.73B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 재개 | Stifel | Buy |
| 2025-05-19 | 재개 | H.C. Wainwright | Buy |
| 2024-04-17 | 개시 | Stifel | Buy |
| 2023-12-18 | 재확인 | H.C. Wainwright | Buy |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-11-13 | 개시 | Morgan Stanley | Overweight |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-17 | 재개 | Evercore ISI | Outperform |
| 2023-09-20 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-01 | 개시 | Citigroup | Buy |
| 2021-09-20 | 개시 | JP Morgan | Overweight |
| 2020-08-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | 개시 | H.C. Wainwright | Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-06-25 | 개시 | Robert W. Baird | Outperform |
| 2019-08-12 | 개시 | Citigroup | Buy |
| 2019-08-12 | 개시 | Evercore ISI | Outperform |
| 2019-08-12 | 개시 | Guggenheim | Buy |
| 2019-08-12 | 개시 | ROTH Capital | Buy |
| 2019-08-12 | 개시 | Raymond James | Outperform |
모두보기
Mirum Pharmaceuticals Inc 주식(MIRM)의 최신 뉴스
Mirum Pharmaceuticals stock reaches all-time high of 75.8 USD - Investing.com
Real time scanner hits for Mirum Pharmaceuticals Inc. explained2025 Short Interest & Daily Profit Focused Screening - Newser
Does Mirum Pharmaceuticals Inc. show high probability of reboundJuly 2025 Spike Watch & Verified Swing Trading Watchlist - Newser
Signal strength of Mirum Pharmaceuticals Inc. stock in tech scannersEarnings Recap Report & Capital Efficient Trade Techniques - Newser
Multi factor analysis applied to Mirum Pharmaceuticals Inc.Weekly Stock Report & Risk Controlled Swing Alerts - Newser
Chart overlay techniques for tracking Mirum Pharmaceuticals Inc.Market Performance Recap & Smart Money Movement Alerts - Newser
Forecasting Mirum Pharmaceuticals Inc. price range with options dataPortfolio Gains Report & Technical Confirmation Trade Alerts - Newser
Is Mirum Pharmaceuticals Inc. impacted by rising ratesSwing Trade & Real-Time Buy Zone Alerts - khodrobank.com
Is Mirum Pharmaceuticals Inc. showing signs of accumulationMarket Movement Recap & High Accuracy Buy Signal Tips - Newser
Does Mirum Pharmaceuticals Inc. have strong fundamentalsJuly 2025 Breakouts & Risk Managed Investment Strategies - khodrobank.com
How high can Mirum Pharmaceuticals Inc. stock goEarnings Risk Report & Free Real-Time Volume Trigger Notifications - Newser
Sentiment analysis tools applied to Mirum Pharmaceuticals Inc.2025 Key Lessons & Daily Technical Forecast Reports - Newser
What are Mirum Pharmaceuticals Inc.’s earnings expectationsPortfolio Growth Summary & High Conviction Buy Zone Alerts - khodrobank.com
Strategies to average down on Mirum Pharmaceuticals Inc.July 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - Newser
Alagille Syndrome Market to Evolve Rapidly Over the Next Decade by 2034, DelveInsight Observes | Takeda, Mirum Pharmaceuticals, Albireo - Barchart.com
How to interpret RSI for Mirum Pharmaceuticals Inc. stockQuarterly Profit Report & Real-Time Volume Analysis - Newser
What indicators show strength in Mirum Pharmaceuticals IncWeekly Trend Report & Capital Efficiency Focused Strategies - Newser
Using Ichimoku Cloud for Mirum Pharmaceuticals Inc. technicals2025 Bull vs Bear & Risk Adjusted Buy and Sell Alerts - Newser
Applying big data sentiment scoring on Mirum Pharmaceuticals Inc.July 2025 Decliners & Fast Entry Momentum Alerts - Newser
Is Mirum Pharmaceuticals Inc. stock forming a triangle pattern2025 Major Catalysts & Advanced Technical Analysis Signals - khodrobank.com
Will Mirum Pharmaceuticals Inc. benefit from seasonalityEarnings Risk Report & Capital Protection Trading Alerts - khodrobank.com
Will Mirum Pharmaceuticals Inc. stock hit new highs in YEAR2025 Volatility Report & Safe Swing Trade Setup Alerts - khodrobank.com
What is Mirum Pharmaceuticals Inc. s debt to equity ratio2025 Winners & Losers & AI Powered Buy and Sell Recommendations - khodrobank.com
What’s next for Mirum Pharmaceuticals Inc. stock pricePortfolio Profit Report & Verified Swing Trading Watchlists - Newser
Trend Dashboard Flags Mirum Pharmaceuticals Inc. As Potential Swing Trade getLinesFromResByArray error: size == 0 - thegnnews.com
Can Mirum Pharmaceuticals Inc. deliver consistent dividends2025 Stock Rankings & Free Community Consensus Stock Picks - beatles.ru
Applying Elliott Wave Theory to Mirum Pharmaceuticals Inc.2025 Momentum Check & Free Community Supported Trade Ideas - Newser
What indicators show strength in Mirum Pharmaceuticals Inc.Earnings Miss & Stock Portfolio Risk Management - Newser
Will Mirum Pharmaceuticals Inc. stock recover after recent dropInsider Buying & Expert Verified Stock Movement Alerts - Newser
Using Bollinger Bands to evaluate Mirum Pharmaceuticals Inc.2025 Winners & Losers & Long-Term Growth Plans - Newser
Mirum Pharmaceuticals Inc. Shows Risk Reward Favoring UpsideJuly 2025 Volume & Advanced Technical Signal Analysis - beatles.ru
Visual trend scoring systems applied to Mirum Pharmaceuticals Inc.Trade Entry Summary & Weekly Watchlist of Top Performers - Newser
Mirum Pharmaceuticals (NASDAQ:MIRM) Rating Lowered to "Buy" at Wall Street Zen - MarketBeat
Mirum Pharmaceuticals Inc (MIRM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Mirum Pharmaceuticals Inc 주식 (MIRM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Peetz Christopher | CHIEF EXECUTIVE OFFICER |
Aug 11 '25 |
Option Exercise |
2.94 |
40,000 |
117,440 |
178,641 |
| Peetz Christopher | CHIEF EXECUTIVE OFFICER |
Aug 11 '25 |
Sale |
62.00 |
40,000 |
2,480,000 |
138,641 |
1.75%
1.11%
자본화:
|
볼륨(24시간):